Phototherapy Equipment Market Size - Share Outlook, Growth Analysis Report and Forecast Trends 2026-2030

Phototherapy equipment includes narrowband UVB broadband UVB booths, excimer laser systems, LED-based devices, and phototherapy units for neonatal jaundice. The market serves hospitals, dermatology clinics, research institutions, and a growing home-use segment, with product designs spanning stationary full-body cabinets, handheld targeted applicators, and compact units tailored for specific indications. Disease prevalence trends, reimbursement policies, and clinical guidelines broadly determine utilization, while the overall market sits in a mid-hundreds-of-millions-of-dollars global range as of 2026.

• •Primary indications: psoriasis, atopic dermatitis, vitiligo, and neonatal hyperbilirubinemia
• •Key end users: hospitals, dermatology clinics, home-care patients, and research settings
• •Product types: full-body UV booths, targeted LED devices, excimer lasers, and infant bilirubin phototherapy units

Rising global incidence of autoimmune and inflammatory skin disorders, particularly psoriasis and atopic dermatitis, is expanding the addressable patient population and increasing demand for proven, non-systemic treatment options. Phototherapy offers cost-effective, non-pharmacological management that is well-suited to long-term chronic disease care, supporting repeat adoption in outpatient dermatology settings. Favorable reimbursement pathways in developed healthcare systems and growing medical infrastructure in Asia-Pacific and Latin America further underpin market expansion.

• •Increasing prevalence of chronic skin conditions globally, especially in aging populations
• •Growing preference for non-systemic, evidence-based treatment alternatives to biologics
• •Expanding neonatal healthcare infrastructure and jaundice screening programs in developing nations

The market splits broadly into product type, UV-based booths, targeted LED devices, and neonatal bilirubin units, and end-use setting, hospital/institutional versus home care. Geographically, North America and Western Europe remain the largest revenue contributors due to high disease prevalence, advanced clinical adoption, and favorable reimbursement, while Asia-Pacific is the fastest-growing region driven by rising healthcare access, growing dermatology awareness, and large population bases in China and India. Emerging markets in Latin America and the Middle East represent smaller but expanding opportunities as their medical device sectors modernize.

• •North America and Western Europe lead in revenue, supported by mature dermatology markets and insurance coverage
• •Asia-Pacific is the fastest-growing region, propelled by rising healthcare access and population scale
• •Home-use phototherapy is a growing sub-segment as compact, user-friendly LED devices gain acceptance

Who are the notable companies in the industry?

The market is moderately fragmented, with a mix of large diversified medical technology groups that offer phototherapy as part of broader dermatological or hospital equipment portfolios, alongside smaller specialty manufacturers that focus exclusively on phototherapy and light-based devices. Integration across the value chain varies: some producers control key component sourcing and proprietary light-source technology, while others rely on external suppliers for UV lamp arrays, LED modules, and electronic controls. Manufacturing and R&D capacity is concentrated in North America, Western Europe, and select East Asian locations, with regional regulatory requirements shaping product development and market entry.

• •Moderately fragmented structure with a blend of diversified medical technology firms and specialty producers
• •Core technology routes include narrowband UVB lamp arrays, LED semiconductor emitters, and excimer laser sources
• •Production and development capacity is concentrated in North America, Europe, and East Asia

What are the recent trends and outlook?

LED-based phototherapy is gaining share over conventional fluorescent UV systems due to superior energy efficiency, longer operational lifetimes, lower heat output, and the ability to tune wavelengths more precisely for specific indications. Home-use and portable devices are an expanding segment as regulatory approvals for smaller-form-factor units enable patient self-management of chronic conditions. Looking ahead, the combination of a rising chronic disease burden, technological improvements in light delivery, and continued penetration in emerging markets is expected to sustain the market's mid-single-digit annual growth trajectory through the early 2030s.

• •LED and targeted devices are displacing older fluorescent-based systems on efficiency and precision
• •Home-use portable phototherapy is growing as clinical evidence and regulatory clearance expand
• •Mid-single-digit CAGR expected over the forecast horizon, underpinned by emerging-market demand and technological advancement